Drugs / MMR
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01000311 Background | Nov 2009 → Nov 2011 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01000311 ↗ |
| Route | Subcutaneous | “Subcutaneous (SC) injection of 1 dose of 0.5 mL of MMR” NCT01000311 ↗ |